Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02935270 · ClinicalTrials.gov registry record
Examining Measurement of Behavioral Neglect Post Stroke
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 55
- Enrollment target
NCT02935270: Completed study, sponsored by Medical University of South Carolina.
NCT02935270 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 55 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02935270 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 55 participants
- Enrollment target
Study Summary
The purpose of this study is to examine measurement of unilateral neglect post stroke. Although a number of clinical assessments are used to measure neglect, it is unclear whether items from some of the most commonly used assessments are able to effectively and comprehensively measure neglect. This study will determine whether these assessments measure different aspects of neglect and whether items from various neglect assessments can be combined to more effectively measure neglect.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2016-01 |
| Est. Completion | 2020-02-21 |
What the finished NCT02935270 record still lists
NCT02935270 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 55 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02935270 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02935270 about?
NCT02935270 is a clinical study titled "Examining Measurement of Behavioral Neglect Post Stroke". The purpose of this study is to examine measurement of unilateral neglect post stroke. Although a number of clinical assessments are used to measure neglect, it is unclear whether items from some of the most commonly used assessments are able to effectively and comprehensively measure neglect. This ...
What is the current status of trial NCT02935270?
This trial is currently completed. The enrollment target is 55 participants. The study started on 2016-01. Estimated completion is 2020-02-21.
Who is sponsoring clinical trial NCT02935270?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01638676 · 55 participants · Phase 1
A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
- NCT01906385 · 55 participants · Phase 1
Maximum Tolerated Dose, Safety, and Efficacy of Rhenium Nanoliposomes in Recurrent Glioma (ReSPECT)
- NCT03007030 · 55 participants · Phase 2
Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery
- NCT03152058 · 55 participants · Phase 2
IMPACT Study: IMProve Pregnancy in APS With Certolizumab Therapy
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia